Relative bioavailability of diazoxide, manufactured at two different international locations, in healthy participants under fasting conditions: an open-label, two-stage, adaptive, sequential two-period crossover study
Crossref DOI link: https://doi.org/10.1186/s41120-017-0013-x
Published Online: 2017-05-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Behm, Martin Otto
Xu, Jialin
Panebianco, Deborah
Fackler, Paul
Funding for this research was provided by:
Merck and Co. Inc
License valid from 2017-05-05